文献

J-GLOBAL ID：201602270119090908   整理番号：16A1315648

腫瘍体積は非小細胞肺癌における突然変異検出を目的とした無細胞DNA配列決定の実行可能性を決定する

Tumor volume determines the feasibility of cell-free DNA sequencing for mutation detection in non-small cell lung cancer

著者 (13件)： Ohira Tatsuo (Department of Surgery, Tokyo Medical University, Tokyo, Japan) ,  Sakai Kazuko (Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan) ,  Matsubayashi Jun (Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan) ,  Kajiwara Naohiro (Department of Surgery, Tokyo Medical University, Tokyo, Japan) ,  Kakihana Masatoshi (Department of Surgery, Tokyo Medical University, Tokyo, Japan) ,  Hagiwara Masaru (Department of Surgery, Tokyo Medical University, Tokyo, Japan) ,  Hibi Masaaki (Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan) ,  Yoshida Koichi (Department of Surgery, Tokyo Medical University, Tokyo, Japan) ,  Maeda Junichi (Department of Surgery, Tokyo Medical University, Tokyo, Japan) ,  Ohtani Keishi (Department of Surgery, Tokyo Medical University, Tokyo, Japan) ,  Nagao Toshitaka (Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan) ,  Nishio Kazuto (Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan) ,  Ikeda Norihiko (Department of Surgery, Tokyo Medical University, Tokyo, Japan)
資料名： Cancer Science (Web)  (Cancer Science (Web))
巻： 107  号： 11  ページ： 1660-1666  発行年： 2016年 
JST資料番号： U0505A  ISSN： 1349-7006  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 次世代シークエンシング(NGS)およびデジタルPCR技術によ...

シソーラス用語： 体積 ,...
準シソーラス用語： 腫瘍体積 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1315648&from=J-GLOBAL&jstjournalNo=U0505A") }}

著者キーワード (5件)： Cell-free DNA ,  mutation ,  non-small cell lung cancer ,  sequencing ,  tumor volume

分類 (2件)： 腫ようの診断  (GE03020J) ,  呼吸器の腫よう  (GI04000G)

引用文献 (19件)：

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
• Takeda M, Sakai K, Terashima M et al. Clinical application of ampliconbased next-generation sequencing to therapeutic decision making in lung cancer. Ann Oncol 2015; 26: 2477-82.
• van der Drift MA, Hol BE, Klaassen CH et al. Circulating DNA is a noninvasive prognostic factor for survival in non-small cell lung cancer. Lung Cancer 2010; 68: 283-7.
• Lee YJ, Yoon KA, Han JY et al. Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. Clin Cancer Res 2011; 17: 5179-87.
• Couraud S, Vaca-Paniagua F, Villar S et al. Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT- 1002. Clin Cancer Res 2014; 20: 4613-24.

タイトルに関連する用語 (5件)： 腫瘍体積 ,  非小細胞肺癌 ,  突然変異検出 ,  無細胞DNA ,  実行可能性